Technical Analysis for PFE - Pfizer, Inc.

Grade Last Price % Change Price Change
F 36.5 -0.63% -0.23
PFE closed down 0.63 percent on Wednesday, January 20, 2021, on 71 percent of normal volume.
Earnings due: Jan 26
*** please verify all earnings dates ***
107 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical PFE trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
200 DMA Resistance Bearish -0.63%
Bollinger Band Squeeze Range Contraction -0.63%
BB Squeeze Started Range Contraction -0.63%
Narrow Range Bar Range Contraction -0.54%
Doji - Bullish? Reversal -0.54%
Down 3 Days in a Row Weakness -0.54%
Down 4 Days in a Row Weakness -0.54%
Fell Below 200 DMA Bearish -0.68%
Older End-of-Day Signals for PFE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Pfizer, Inc. Description

Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care physicians for Alzheimer's disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation therapeutic and disease areas. The company's Specialty Care and Oncology segment provides human prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. Its Established Products and Emerging Markets segment offers human prescription pharmaceutical products that have lost patent protection or marketing exclusivity in certain countries and/or regions, as well as that are sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. The company's Animal Health segment offers products and services to prevent and treat disease in livestock and companion animals, including anti-infectives, vaccines, parasiticides, medicinal feed additives, other pharmaceutical products, and other non-pharmaceutical products. Its Consumer Healthcare segment provides non-prescription products in therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. has a strategic collaboration with CytomX Therapeutics, Inc. to develop and commercialize Multiple Probody drug conjugates in oncology. The company was founded in 1849 and is headquartered in New York, New York.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Biopharmaceutical Pharmaceutical Industry Pain Disease Clinics Pharmaceutical Products Medication Inflammation Hypertension Neuroscience Animal Health Dysfunction Alzheimer's Disease Ophthalmology Pain Management Dietary Supplements Depressive Disorder Pulmonary Arterial Hypertension Dietary Supplement Major Depressive Disorder Glaxosmithkline Hemophilia Primary Care Smoking Smoking Cessation Anti Infectives Prescription Product Prescription Products Endocrine Disorders Livestock Producers Cardiovascular Erectile Dysfunction Genitourinary

Is PFE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 43.08
52 Week Low 27.88
Average Volume 49,809,729
200-Day Moving Average 36.88
50-Day Moving Average 37.94
20-Day Moving Average 36.99
10-Day Moving Average 36.96
Average True Range 0.72
ADX 11.75
+DI 20.31
-DI 24.12
Chandelier Exit (Long, 3 ATRs ) 35.95
Chandelier Exit (Short, 3 ATRs ) 38.44
Upper Bollinger Band 37.60
Lower Bollinger Band 36.38
Percent B (%b) 0.1
BandWidth 3.28
MACD Line -0.39
MACD Signal Line -0.37
MACD Histogram -0.024
Fundamentals Value
Market Cap 202.88 Billion
Num Shares 5.56 Billion
EPS 1.54
Price-to-Earnings (P/E) Ratio 23.73
Price-to-Sales 4.22
Price-to-Book 3.11
PEG Ratio 5.22
Dividend 1.52
Dividend Yield 4.16%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 37.03
Resistance 3 (R3) 37.07 36.94 36.94
Resistance 2 (R2) 36.94 36.81 36.92 36.91
Resistance 1 (R1) 36.72 36.72 36.66 36.68 36.88
Pivot Point 36.59 36.59 36.56 36.57 36.59
Support 1 (S1) 36.37 36.46 36.31 36.33 36.12
Support 2 (S2) 36.24 36.37 36.22 36.09
Support 3 (S3) 36.02 36.24 36.06
Support 4 (S4) 35.98